Market Access

Find out everything you need to know about the latest pricing, reimbursement and market access strategies that will drive your business development.

5 Easy Steps to Success in the New Life Sciences Job Market

Contributor: EPM Scientific
Posted: 7/7/2014

2014 has seen a dramatic switch in the hiring market. The improved global economic climate has triggered an aggressive appetite for growth, leaving the hiring freezes, redundancies and job insecurity that once characterised the job market behind. Firms are once again looking for the best human capital to fuel their future growth plans, job vacancies are escalating and opportunity is rife. Full Article »

Events related to this topic:

Preventing Type 2 Diabetes in the MENA Region

Contributor: Andrea Charles
Posted: 12/20/2011

Preventing Type 2 Diabetes in the MENA Region - Andrea Charles

Diabetes is a global threat. Researchers estimate that 26.6 million people in the Middle East and North Africa currently have diabetes. Six countries in the region are among the top 10 globally with the highest prevalence of diabetes. In this interview diabetes expert Professor Peter Schwarz, talks about the alarming growth of diabetes in the MENA region and strategies for prevention and management. Full Podcast »

Events related to this topic:

OpEx for 2013 – Crystal Ball Predictions

Contributor: Jon Wetzel
Posted: 3/8/2013

OpEx for 2013 – Crystal Ball Predictions - Jon Wetzel

To look forward we need to first look back. From 2008-2012 we saw big pharma collide creating larger companies. Genentech-Roche, Novartis-Alcon, Pfizer-Wyeth and GlaxoSmithKline-Human Genome Sciences just to name a few. During this same time frame the economies of the world have seen crashes and upheavals causing some of these same companies to “trim” their workforces. What does all this mean for 2013? Full Column »

Events related to this topic:

The Antidote: Taking a Look at “Pharmerging” Markets and the Resurgence in UK Biotech IPOs

Pharma IQ is proud to bring you the latest edition of The Antidote, the quarterly lifesciences newsletter from Europe’s largest law firm, CMS. This edition focuses on the increasing opportunities in Asia, and the resurgence of the UK biotech IPO. Full Whitepaper »

Events related to this topic:

Advertise With Us

Join the Pharmas IQ Community